Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines -- 25+ years of biotherapeutics leadership, including serving as ...
Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP(TM) (Mercury ...
Figure 1: The protein-kinase-A inhibitor H-89 inhibits host kinases that control intracellular Salmonella typhimurium growth. Figure 3: Identification of host kinases controlling intracellular growth ...
As a grad student in cell biology, Shaeri Mukherjee was always on the lookout for new ways to fiddle with cells’ internal structures. It was the early 2000s, and Mukherjee was working in Dennis ...
Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP™ (Mercury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback